Dr. Ola Landgren, Head of the Multiple Myeloma Section in CCR's Medical Oncology Branch, takes you into his lab and clinic where he is studying two pre-myeloma conditions, patients with abnormal M-protein levels in their blood, and patients with smoldering multiple myeloma, a precursor disease that often transforms into multiple myeloma. He will show you how his natural history study of pre-myeloma patients will try to find treatments that can intervene earlier and keep the myeloma from progressing to a life-threatening disease.
A service of the National Cancer Institute
